ProPhase Labs, Inc. Due from Banks
ProPhase Labs, Inc. (PRPH) had Due from Banks of $5.30 million as of 2015-03-31, per its 10-Q filed 2015-05-13.
Discontinued › Balance Sheet › Assets
us-gaap:DueFromBanks · last filed 2015-05-13
- 2015-03-31: Due from Banks $5.30M.
- 2014-12-31: Due from Banks $3.10M.
- 2014-09-30: Due from Banks $5.00M.
- 2014-06-30: Due from Banks $7.60M.
| Period end | Due from Banks |
|---|---|
| 2015-03-31 | $5.30M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $3.10M 10-K · filed 2015-03-27 |
| 2014-09-30 | $5.00M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $7.60M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $5.70M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $1.80M 10-K · filed 2014-03-27 |
| 2013-09-30 | $1.50M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $4.40M 10-Q · filed 2013-08-13 |
| 2013-03-31 | $4.70M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $1.10M 10-K · filed 2013-03-28 |
| 2012-09-30 | $2.40M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $4.90M 10-Q · filed 2012-08-13 |
| 2010-12-31 | $1.80M 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |